The SPIRO-MOTE Study

Multicentre Prospective Cohort Study of Remote Lung Function Testing in Children: Validation and Comparison of Supervised and Unsupervised Spirometry

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05960344

Enrollment

Registered

2023-07-25

Start date

2021-02-24

Completion date

2022-05-31

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spirometry

Brief summary

Multicentre Prospective Cohort Study of Remote Lung Function Testing in Children: validation and comparison of supervised and unsupervised spirometry

Interventions

PROCEDURESpirometry

Supervised v unsupervised spirometry

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 16 Years

Inclusion criteria

* Male and female children aged 5 to 16 years old * Doctor diagnosed respiratory condition, including asthma, cystic fibrosis, PCD, bronchiectasis * Child able to perform reliable spirometry * Family have access to a smartphone or tablet and a second device for video consultation

Exclusion criteria

* Significant learning difficulties * Other reasons for being unable to do lung function tests, for example, unable to make a seal around the mouthpiece * Informed consent/assent has not been provided * No English speaking member of the family * Contraindications as outlined by the ARTP, e.g. pneumothorax, haemoptysis of unknown origin, unstable cardiovascular status, recent eye surgery, vomiting or any acute disease that would interfere with the test performance, recent surgery (thoracic/abdominal)

Design outcomes

Primary

Measure	Time frame	Description
Outcome measures from spirometry tests (1)	Within two weeks	The researchers will use the absolute values for FEV1 and FVC, coupled with the demographic data, to calculate FEV1/FVC, percent predicted and z-scores using a batch calculator from the GLI website. The team will record how many patients achieved technically acceptable tests, using the ATS A-F standards (9), and how many failed.
Outcome measures from spirometry tests (2)	Within two weeks	The team will record how many patients achieved technically acceptable tests, using the ATS A-F standards (9), and how many failed.
Length of each standard test	Within two weeks	Researchers will record how long each standard test took to carry out.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026